TY - JOUR AU - Stone, A. AU - Cooper, J. AU - Koenig, K. L. AU - Golfinos, J. G. AU - Oratz, R. PY - 2004 DA - 2004// TI - A comparison of survival rates for treatment of melanoma metastatic to the brain JO - Cancer Invest VL - 22 UR - https://doi.org/10.1081/CNV-200026387 DO - 10.1081/CNV-200026387 ID - Stone2004 ER - TY - JOUR AU - Miranda, E. P. PY - 2004 DA - 2004// TI - Management of cutaneous melanoma JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJM200412233512620 DO - 10.1056/NEJM200412233512620 ID - Miranda2004 ER - TY - JOUR AU - Wroblewski, D. PY - 2013 DA - 2013// TI - The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance JO - Carcinogenesis VL - 34 UR - https://doi.org/10.1093/carcin/bgs330 DO - 10.1093/carcin/bgs330 ID - Wroblewski2013 ER - TY - JOUR AU - Peng, Y. AU - Song, J. AU - Lu, J. AU - Chen, X. PY - 2007 DA - 2007// TI - The histone deacetylase inhibitor sodium butyrate inhibits baculovirus-mediated transgene expression in Sf9 cells JO - J Biotechnol VL - 131 UR - https://doi.org/10.1016/j.jbiotec.2007.06.009 DO - 10.1016/j.jbiotec.2007.06.009 ID - Peng2007 ER - TY - JOUR AU - Kuwajima, A. AU - Iwashita, J. AU - Murata, J. AU - Abe, T. PY - 2007 DA - 2007// TI - The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel JO - Anticancer Res VL - 27 ID - Kuwajima2007 ER - TY - JOUR AU - Munshi, A. PY - 2005 DA - 2005// TI - Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2088 DO - 10.1158/1078-0432.CCR-04-2088 ID - Munshi2005 ER - TY - JOUR AU - Beppu, T. PY - 1986 DA - 1986// TI - Analysis and application of microbial functions JO - Nippon Nogeik Kaishi VL - 60 UR - https://doi.org/10.1271/nogeikagaku1924.60.529 DO - 10.1271/nogeikagaku1924.60.529 ID - Beppu1986 ER - TY - JOUR AU - Duvic, M. PY - 2007 DA - 2007// TI - Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-06-025999 DO - 10.1182/blood-2006-06-025999 ID - Duvic2007 ER - TY - JOUR AU - Whittaker, S. J. PY - 2010 DA - 2010// TI - Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.9066 DO - 10.1200/JCO.2010.28.9066 ID - Whittaker2010 ER - TY - JOUR AU - Piekarz, R. L. PY - 2009 DA - 2009// TI - Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.6150 DO - 10.1200/JCO.2008.21.6150 ID - Piekarz2009 ER - TY - JOUR AU - Nebbioso, A. AU - Carafa, V. AU - Benedetti, R. AU - Altucci, L. PY - 2012 DA - 2012// TI - Trials with ‘epigenetic’ drugs: an update JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.09.004 DO - 10.1016/j.molonc.2012.09.004 ID - Nebbioso2012 ER - TY - JOUR AU - Qiu, T. PY - 2013 DA - 2013// TI - Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials JO - Future Oncol VL - 9 UR - https://doi.org/10.2217/fon.12.173 DO - 10.2217/fon.12.173 ID - Qiu2013 ER - TY - JOUR AU - Carew, J. S. AU - Giles, F. J. AU - Nawrocki, S. T. PY - 2008 DA - 2008// TI - Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy JO - Cancer Lett VL - 269 UR - https://doi.org/10.1016/j.canlet.2008.03.037 DO - 10.1016/j.canlet.2008.03.037 ID - Carew2008 ER - TY - JOUR AU - Banerji, U. PY - 2012 DA - 2012// TI - A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-3165 DO - 10.1158/1078-0432.CCR-11-3165 ID - Banerji2012 ER - TY - JOUR AU - Dong, M. PY - 2012 DA - 2012// TI - Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas JO - Cancer Chemother Pharmacol VL - 69 UR - https://doi.org/10.1007/s00280-012-1847-5 DO - 10.1007/s00280-012-1847-5 ID - Dong2012 ER - TY - JOUR AU - Hofmeister, C. C. PY - 2012 DA - 2012// TI - A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-06-438028 DO - 10.1182/blood-2012-06-438028 ID - Hofmeister2012 ER - TY - JOUR AU - Duhovic, C. AU - Child, F. AU - Wain, E. M. PY - 2012 DA - 2012// TI - Management of cutaneous T-cell lymphoma JO - Clin Med (Lond) VL - 12 UR - https://doi.org/10.7861/clinmedicine.12-2-160 DO - 10.7861/clinmedicine.12-2-160 ID - Duhovic2012 ER - TY - STD TI - Evens AM, et al. A Phase II multicenter study of the histone deacetylase inhibitor (HDACi) abexinostat (PCI-24781) in relapsed/refractory follicular lymphoma (FL) and mantle cell lymphoma (MCL). Blood. 2012;120. ID - ref18 ER - TY - JOUR AU - Cho, Y. AU - Sloutsky, R. AU - Naegle, K. M. AU - Cavalli, V. PY - 2013 DA - 2013// TI - Injury-Induced HDAC5 nuclear export Is essential for axon regeneration JO - Cell VL - 155 UR - https://doi.org/10.1016/j.cell.2013.10.004 DO - 10.1016/j.cell.2013.10.004 ID - Cho2013 ER - TY - JOUR AU - Backs, J. AU - Backs, T. AU - Bezprozvannaya, S. AU - McKinsey, T. A. AU - Olson, E. N. PY - 2008 DA - 2008// TI - Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4 JO - Mol Cell Biol VL - 28 UR - https://doi.org/10.1128/MCB.01611-07 DO - 10.1128/MCB.01611-07 ID - Backs2008 ER - TY - JOUR AU - Lemercier, C. PY - 2000 DA - 2000// TI - mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M908437199 DO - 10.1074/jbc.M908437199 ID - Lemercier2000 ER - TY - JOUR AU - Lu, J. R. AU - McKinsey, T. A. AU - Nicol, R. L. AU - Olson, E. N. PY - 2000 DA - 2000// TI - Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases JO - Proc Natl Acad Sci USA VL - 97 UR - https://doi.org/10.1073/pnas.080064097 DO - 10.1073/pnas.080064097 ID - Lu2000 ER - TY - JOUR AU - McGee, S. L. PY - 2008 DA - 2008// TI - AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5 JO - Diabetes VL - 57 UR - https://doi.org/10.2337/db07-0843 DO - 10.2337/db07-0843 ID - McGee2008 ER - TY - JOUR AU - Agis-Balboa, R. C. AU - Pavelka, Z. AU - Kerimoglu, C. AU - Fischer, A. PY - 2013 DA - 2013// TI - Loss of HDAC5 impairs memory function: implications for alzheimer’s disease JO - J Alzheimers Dis VL - 33 ID - Agis-Balboa2013 ER - TY - JOUR AU - Gao, Y. S. PY - 2007 DA - 2007// TI - Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis JO - Mol Cell Biol VL - 27 UR - https://doi.org/10.1128/MCB.00393-07 DO - 10.1128/MCB.00393-07 ID - Gao2007 ER - TY - JOUR AU - Tran, A. D. A. PY - 2007 DA - 2007// TI - HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions JO - J Cell Sci VL - 120 UR - https://doi.org/10.1242/jcs.03431 DO - 10.1242/jcs.03431 ID - Tran2007 ER - TY - JOUR AU - Zilberman, Y. PY - 2009 DA - 2009// TI - Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6 JO - J Cell Sci VL - 122 UR - https://doi.org/10.1242/jcs.046813 DO - 10.1242/jcs.046813 ID - Zilberman2009 ER - TY - JOUR AU - Lee, Y. S. PY - 2008 DA - 2008// TI - The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0188 DO - 10.1158/0008-5472.CAN-08-0188 ID - Lee2008 ER - TY - JOUR AU - Kovacs, J. J. PY - 2005 DA - 2005// TI - HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor JO - Mol Cell VL - 18 UR - https://doi.org/10.1016/j.molcel.2005.04.021 DO - 10.1016/j.molcel.2005.04.021 ID - Kovacs2005 ER - TY - JOUR AU - Kwon, S. AU - Zhang, Y. AU - Matthias, P. PY - 2007 DA - 2007// TI - The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response JO - Genes Dev VL - 21 UR - https://doi.org/10.1101/gad.461107 DO - 10.1101/gad.461107 ID - Kwon2007 ER - TY - JOUR AU - Seigneurin-Berny, D. PY - 2001 DA - 2001// TI - Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways JO - Mol Cell Biol VL - 21 UR - https://doi.org/10.1128/MCB.21.23.8035-8044.2001 DO - 10.1128/MCB.21.23.8035-8044.2001 ID - Seigneurin-Berny2001 ER - TY - JOUR AU - Li, Q. PY - 2009 DA - 2009// TI - Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells JO - Cancer Lett VL - 278 UR - https://doi.org/10.1016/j.canlet.2008.12.032 DO - 10.1016/j.canlet.2008.12.032 ID - Li2009 ER - TY - JOUR AU - Hou, J. AU - Liu, Y. AU - Shao, Y. PY - 2012 DA - 2012// TI - The MSHA strain of Pseudomonas aeruginosa activated TLR pathway and enhanced HIV-1 DNA vaccine immunoreactivity JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0047724 DO - 10.1371/journal.pone.0047724 ID - Hou2012 ER - TY - JOUR AU - Lei, Q. PY - 2006 DA - 2006// TI - NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss JO - Cancer Cell VL - 9 UR - https://doi.org/10.1016/j.ccr.2006.03.031 DO - 10.1016/j.ccr.2006.03.031 ID - Lei2006 ER - TY - JOUR AU - Liu, Z. B. PY - 2010 DA - 2010// TI - Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.70 DO - 10.1038/onc.2010.70 ID - Liu2010 ER - TY - JOUR AU - Fan, J. PY - 2014 DA - 2014// TI - Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest JO - Tumour Biol ID - Fan2014 ER - TY - JOUR AU - Qin, H. X. PY - 2012 DA - 2012// TI - HDAC6 siRNA inhibits proliferation and induces apoptosis of HeLa cells and its related molecular mechanism JO - Asian Pac J Cancer Prev VL - 13 UR - https://doi.org/10.7314/APJCP.2012.13.7.3367 DO - 10.7314/APJCP.2012.13.7.3367 ID - Qin2012 ER - TY - JOUR AU - Giorgio, E. AU - Gagliostro, E. AU - Clocchiatti, A. AU - Brancolini, C. PY - 2015 DA - 2015// TI - The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase JO - Mol Cell Biol VL - 35 UR - https://doi.org/10.1128/MCB.01461-14 DO - 10.1128/MCB.01461-14 ID - Giorgio2015 ER - TY - JOUR AU - Nussbaum, E. S. AU - Djalilian, H. R. AU - Cho, K. H. AU - Hall, W. A. PY - 1996 DA - 1996// TI - Brain metastases. Histology, multiplicity, surgery, and survival JO - Cancer VL - 78 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Nussbaum1996 ER - TY - JOUR AU - Medina, V. PY - 1997 DA - 1997// TI - Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway JO - Cancer Res VL - 57 ID - Medina1997 ER - TY - JOUR AU - Qiu, L. PY - 2000 DA - 2000// TI - Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells JO - Mol Biol Cell VL - 11 UR - https://doi.org/10.1091/mbc.11.6.2069 DO - 10.1091/mbc.11.6.2069 ID - Qiu2000 ER - TY - JOUR AU - Richon, V. M. AU - Sandhoff, T. W. AU - Rifkind, R. A. AU - Marks, P. A. PY - 2000 DA - 2000// TI - Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation JO - Proc Natl Acad Sci USA VL - 97 UR - https://doi.org/10.1073/pnas.180316197 DO - 10.1073/pnas.180316197 ID - Richon2000 ER - TY - JOUR AU - Marks, P. PY - 2001 DA - 2001// TI - Histone deacetylases and cancer: causes and therapies JO - Nat Rev Cancer VL - 1 UR - https://doi.org/10.1038/35106079 DO - 10.1038/35106079 ID - Marks2001 ER - TY - JOUR AU - Jeon, E. J. PY - 2006 DA - 2006// TI - Bone morphogenetic protein-2 stimulates Runx2 acetylation JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M512494200 DO - 10.1074/jbc.M512494200 ID - Jeon2006 ER - TY - JOUR AU - Lv, L. PY - 2013 DA - 2013// TI - Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization JO - Mol Cell VL - 52 UR - https://doi.org/10.1016/j.molcel.2013.09.004 DO - 10.1016/j.molcel.2013.09.004 ID - Lv2013 ER - TY - JOUR AU - Wang, B. PY - 2014 DA - 2014// TI - Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production JO - Nat Commun VL - 5 ID - Wang2014 ER - TY - JOUR AU - Bertos, N. R. PY - 2004 DA - 2004// TI - Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M408583200 DO - 10.1074/jbc.M408583200 ID - Bertos2004 ER - TY - JOUR AU - Ruijter, A. J. AU - Gennip, A. H. AU - Caron, H. N. AU - Kemp, S. AU - Kuilenburg, A. B. PY - 2003 DA - 2003// TI - Histone deacetylases (HDACs): characterization of the classical HDAC family JO - Biochem J VL - 370 UR - https://doi.org/10.1042/bj20021321 DO - 10.1042/bj20021321 ID - Ruijter2003 ER - TY - JOUR AU - Pandey, U. B. PY - 2007 DA - 2007// TI - HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS JO - Nature VL - 447 UR - https://doi.org/10.1038/nature05853 DO - 10.1038/nature05853 ID - Pandey2007 ER - TY - JOUR AU - Mihaylova, M. M. PY - 2011 DA - 2011// TI - Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis JO - Cell VL - 145 UR - https://doi.org/10.1016/j.cell.2011.03.043 DO - 10.1016/j.cell.2011.03.043 ID - Mihaylova2011 ER - TY - JOUR AU - Yang, M. H. PY - 2013 DA - 2013// TI - HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS JO - Mol Cancer Res VL - 11 UR - https://doi.org/10.1158/1541-7786.MCR-13-0040-T DO - 10.1158/1541-7786.MCR-13-0040-T ID - Yang2013 ER - TY - JOUR AU - Baertschi, S. AU - Baur, N. AU - Lueders-Lefevre, V. AU - Voshol, J. AU - Keller, H. PY - 2014 DA - 2014// TI - Class I and IIa histone deacetylases have opposite effects on sclerostin Gene regulation JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M114.564997 DO - 10.1074/jbc.M114.564997 ID - Baertschi2014 ER - TY - JOUR AU - Lai, F. PY - 2013 DA - 2013// TI - Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3 JO - Cell Death Dis VL - 4 UR - https://doi.org/10.1038/cddis.2013.192 DO - 10.1038/cddis.2013.192 ID - Lai2013 ER - TY - JOUR AU - Sun, Y. PY - 2014 DA - 2014// TI - Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.253 DO - 10.1038/onc.2013.253 ID - Sun2014 ER -